【摘 要】 目的：利培酮与富马酸喹硫平治疗精神分裂症的临床药学分析。方法：从某医院精神科就诊的患者中抽取50例精神分裂患者，抽取患者这就诊时间为2019年1月至2020年1月，将抽取的患者随机分为研究组和对照组两组，对照组采取富马酸喹硫平进行治疗，研究组采取利培酮进行治疗。治疗一定周期后，比较两组患者的体重以及血脂情况。结果：对所有患者治疗后的体重、体脂进行对比，结果显示研究组明显优于对照组(P<0.05)。结论：采用利培酮与富马酸喹硫平分别对精神分裂患者进行治疗，利培酮的治疗效果更优，同时有效优化患者体重、体脂等各项指标情况，该种治疗方法相比富马酸喹硫平的临床治疗效果有很大的优势，值得在临床上广泛推荐使用。

    【关键詞】 利培酮;富马酸喹硫平;精神分裂症;药学分析

    【中图分类号】R749.3

    【文献标志码】A

    【文章编号】1005-0019(2020)19-019-02

    Abstract：Objective：To analyze the clinical pharmacy of risperidone and quetiapine fumarate in the treatment of schizophrenia. Methods：50 schizophrenic patients were selected from the psychiatric department of a hospital. The patients were selected from January 2019 to January 2020. The patients were randomly divided into two groups： the study group and the control group. The control group was treated with quetiapine fumarate and the study group was treated with risperidone. After a certain period of treatment ......